<DOC>
	<DOCNO>NCT03037736</DOCNO>
	<brief_summary>This randomize controlled trial postoperative bevacizumab 5-fluorouracil subconjunctival injection vs placebo recurrence pterygium excision use conjunctival autograft .</brief_summary>
	<brief_title>Outpatient Performed Pterygium Surgery Study</brief_title>
	<detailed_description>Patients randomize enrollment one three arm : 5-Fluorouracil ( 5-FU ) 5mg/0.1mL , bevacizumab 2.5mg/0.1mL , placebo . The placebo sterile , preservative-free injectable 0.9 % normal saline . All patient undergo pterygium excision surgery minor procedure room use standardized surgical technique conjunctival autograft . All patient standardize postoperative drop protocol neomycin/polymyxin/dexamethasone ointment four time daily 2 week fluorometholone drop 4 time daily 2 week , three time daily 2 week , twice daily 2 week , daily 2 week stop . At 1-month 2-month postoperative visit , patient receive subconjunctival injection base randomization assignment ( 5-FU , bevacizumab placebo ) area excise pterygium least 1 mm posterior limbus . The total injected volume 0.1mL adjuvant . The primary outcome pterygium recurrence 3 month , define evidence least 1 mm fibrovascular growth onto cornea . After 3 month visit , patient determine recurrence unmasked , receive monthly 5-FU bevacizumab injection discretion treat physician . Each visit treat study visit , document . All patient study visit 6 12 month mark . If point patient develop evidence progression recurrence , may undergo monthly 5-FU bevacizumab injection discretion treat physician .</detailed_description>
	<mesh_term>Pterygium</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Patients symptomatic singleheaded primary pterygium extend 2mm onto cornea determine physician good candidate surgical excision . Able express basic understanding study determine treat physician . Age 18 old . Commitment return follow visit Patients pregnant plan become pregnant study period Patients unable tolerate subconjunctival injection clinic set Patients diagnosis glaucoma 1 topical medication control intraocular pressure ocular hypertension pressure great equal 24mmHg . Patients previous history conjunctival surgery eye pterygium Patients history autoimmune inflammatory conjunctival corneal disorder , include limited Stevens Johnson syndrome , graft versus host disease , mucous membrane pemphigoid , severe atopy , herpes simplex epitheliitis keratitis . Patients allergy one study drug . Patients systemic immunosuppressive therapy chemotherapy . Patients condition require topical steroid drop study eye oral prednisone dose 5mg/day . Patients history scleritis severe ocular surface disease limbal stem cell deficiency . Patients poor vision ( define VA 20/200 worse ) contralateral eye . Patients large pterygium judge clinically need amniotic membrane rather conjunctival autograft . Patients biheaded pterygium . Patients unable undergo conjunctival autograft reason . Patients unable give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>